The 2022-23 flu season lingered through the second half of January and most of February at the edge of its defined existence, but it now appears to be over.
from WebMD Health https://ift.tt/PUfsGhw
Friday 10 March 2023
The Future of GA Treatment
Scientists are closer than ever to new therapies for geographic atrophy, an advanced form of the eye disease called dry age-related macular degeneration.
from WebMD Health https://ift.tt/LeJwOrk
Omicron Much Less Likely to Cause Long COVID, Study Finds
Those who tested positive with the original virus had a 67% higher risk of developing long COVID, while the chances of developing long COVID among workers whose first infection was with Omicron did not appear to be greater.
from WebMD Health https://ift.tt/2S4qPcY
F.D.A. Approves New Nasal Spray for Migraines
By BY CHRISTINA JEWETT from NYT Health https://ift.tt/vy5CJuF
FDA Approves Fast-Acting Nasal Spray for Migraines, Pfizer Says
Clinical trials showed the nasal spray provided migraine relief within 15-30 minutes of use, with the relief lasting up to 48 hours in many patients.
from WebMD Health https://ift.tt/OuV3zD9
